Webinar Series:
Investigating Generic Drugs

We all deserve generic drugs that we can trust. Our latest webinar will connect people and healthcare professionals to whistleblowers and industry insiders who are working on real solutions to improve drug quality and safety for everyone.

Register

WEBINAR #2 OF A SERIES | September 24, 2025 4:00–5:30 PM ET

Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

Peter Baker President,
Live Oak Quality Assurance and Former FDA Inspector
Rosemary Gibson Author,
China Rx: Exposing the Risks of America's Dependence on China for Medicine
John Gray, PhD Dean’s Distinguished Professor,
Department of Operations and Business Analytics, Ohio State University
Suzanne Robotti Founder and President,
MedShadow Foundation

REGISTER NOW

LEARN MORE ABOUT OUR WEBINAR SERIES

Watch on Demand

WEBINAR #2 OF A SERIES | September 24, 2025 4:00–5:30 PM ET

Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

REGISTER NOW Watch

WEBINAR #1 OF A SERIES | June 15, 2025

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

WATCH

Upcoming Webinars

WEBINAR #1 OF A SERIES | June 15, 2025

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

WEBINAR #3 OF A SERIES | October 28, 2025

Title and Topic COMING SOON

WEBINAR #4 OF A SERIES |

Title and Topic COMING SOON

Read Related Articles:

INVESTIGATING GENERICS: America’s Overlooked Drug Crisis

INVESTIGATING GENERICS: They Say Their ADHD Meds Aren’t Working. They’re Not Imagining It

INVESTIGATING GENERICS: Hundreds Of Drugs Remain On The Market After Fraudulent Trials

Next

Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

x

x